Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy

被引:0
|
作者
Houshi Xu
Qingwei Zhu
Lan Tang
Junkun Jiang
Huiwen Yuan
Anke Zhang
Meiqing Lou
机构
[1] Shanghai Jiao Tong University School of Medicine,Department of Neurosurgery, Shanghai General Hospital
[2] Zhejiang University,Department of Neurosurgery, Second Affiliated Hospital, School of Medicine
[3] Tongji University,undefined
来源
Cancer Cell International | / 21卷
关键词
Gliomas; Immunotherapy; T cell; FCER1G; biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy
    Xu, Houshi
    Zhu, Qingwei
    Tang, Lan
    Jiang, Junkun
    Yuan, Huiwen
    Zhang, Anke
    Lou, Meiqing
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [2] Prognostic and Predictive Value of BGN in Colon Cancer Outcomes and Response to Immunotherapy
    He, Zi-Xuan
    Zhao, Sheng-Bing
    Fang, Xue
    Fu, Hong-Yu
    Song, Yi-Hang
    Wu, Jia-Yi
    Pan, Peng
    Gu, Lun
    Xia, Tian
    Liu, Yi-Long
    Li, Zhao-Shen
    Wang, Shu-Ling
    Bai, Yu
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [3] CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma
    Jiang, Yuan
    Ji, Qiankun
    Long, Xiaoyan
    Wang, Peng
    Tu, Zewei
    Zhang, Xian
    Zhu, Xingen
    Huang, Kai
    Li, Jingying
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] Identification of FCER1G as a key gene in multiple myeloma based on weighted gene co-expression network analysis
    Qiu, Xiao
    Zhang, Jia-He
    Xu, Ying
    Cao, Yi-Xuan
    Zhang, Rui-Ting
    Hu, Li-Na
    Zhou, Ji-Hao
    HEMATOLOGY, 2023, 28 (01)
  • [5] Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer
    Gao, Mengting
    Wu, Xueying
    Jiao, Xi
    Hu, Ying
    Wang, Yanni
    Zhuo, Na
    Dong, Fengxiao
    Wang, Yujiao
    Wang, Fengyuan
    Cao, Yanshuo
    Liu, Chang
    Li, Jian
    Shen, Lin
    Zhang, Henghui
    Lu, Zhihao
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (02)
  • [6] Analysis of the sodium pump subunit ATP1A3 in glioma patients: Potential value in prognostic prediction and immunotherapy
    Lan, Yu-Long
    Zou, Shuang
    Qin, Bing
    Zhu, Xiangdong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 133
  • [7] The Expression and Prognostic Value of ILK and YAP1 in Glioma
    Wang, Qian
    Sang, Wei
    Xue, Jing
    Zhai, Yangyang
    Hu, Yanran
    Su, Liping
    Zhang, Wei
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022, 30 (03) : E21 - E29
  • [8] Assessing the predictive value of smoking history for immunotherapy outcomes in bladder cancer patients
    Kong, Jianqiu
    Zou, Yitong
    Zhou, Hua
    Huang, Yi
    Lin, Ying
    Fang, Shuogui
    Chen, Zhijian
    Zheng, Junjiong
    Huang, Yaqiang
    Shen, Zefeng
    Xie, Weibin
    Fan, Xinxiang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [9] Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
    Liikanen, Ilkka
    Koski, Anniina
    Merisalo-Soikkeli, Maiju
    Hemminki, Otto
    Oksanen, Minna
    Kairemo, Kalevi
    Joensuu, Timo
    Kanerva, Anna
    Hemminki, Akseli
    ONCOIMMUNOLOGY, 2015, 4 (03): : 1 - 13
  • [10] Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme
    Deng, Longfei
    Ren, Jie
    Li, Benqin
    Wang, Yinggang
    Jiang, Nianfen
    Wang, Yi
    Cui, Hongjuan
    BMC GENOMICS, 2023, 24 (01)